论文信息 - IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy. - 字舞流文

IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy.

D. Gandara | S. Peters | R. Dziadziuszko | B. Solomon | N. Rizvi | A. Sandler | M. Reck | M. Garassino | B. Gitlitz | A. Kim | L. Wang | A. Brunelli | I. To | S. Sun | S. Sun